Emond M, Mock M B, Davis K B, Fisher L D, Holmes D R, Chaitman B R, Kaiser G C, Alderman E, Killip T
Coordinating Center for Collaborative Studies in Coronary Artery Surgery, University of Washington, Seattle 98105.
Circulation. 1994 Dec;90(6):2645-57. doi: 10.1161/01.cir.90.6.2645.
This study describes the impact of clinical, angiographic, and demographic characteristics on the long-term survival of Coronary Artery Surgery Study (CASS) patients while they were under medical treatment. Revascularization rates for the population are also provided.
All CASS patients who had not received heart surgery before enrollment (23,467 patients) were included in this survival analysis while they were under medical treatment or surveillance. Follow-up time ranged from 0 to 17 years (median, 12 years). Long-term vital status is known for 95.8% of these patients. Log-rank tests, Kaplan-Meier survival curves, and Cox proportional-hazards regression are used to describe and assess the impact of patient characteristics on survival. Characteristics that had a significant impact on survival, in order of observed explanatory power, are age, number of diseased vessels, congestive heart failure score, smoking history, ejection fraction, sex, presence of left main coronary artery disease, presence of diabetes, left ventricular wall motion score, presence of other illnesses, history of myocardial infarction, and presence of left main equivalent disease. Overall, 12-year survival for patients with zero-, one-, two- and three-vessel disease is 88%, 74%, 59%, and 40%, respectively. Twelve-year survival for patients with at least one diseased vessel and ejection fractions in the ranges of 50% to 100%, 35% to 49%, and 0% to 34% is 73%, 54%, and 21%, respectively. High myocardial jeopardy, high anginal class, and two or three proximal diseased vessels characterize the profile of patients most likely to have received surgical treatment during follow-up.
These results contribute to the understanding of the natural history of coronary artery disease and are also of historical interest. The poor survival of patients with three-vessel disease and low ejection fractions continues to emphasize the importance of considering revascularization for these patients.
本研究描述了临床、血管造影和人口统计学特征对冠状动脉外科研究(CASS)患者在接受药物治疗期间长期生存的影响。同时还提供了该人群的血运重建率。
所有在入组前未接受心脏手术的CASS患者(23467例)在接受药物治疗或监测期间被纳入本生存分析。随访时间为0至17年(中位数为12年)。这些患者中95.8%的长期生命状态已知。采用对数秩检验、Kaplan-Meier生存曲线和Cox比例风险回归来描述和评估患者特征对生存的影响。按观察到的解释力顺序,对生存有显著影响的特征包括年龄、病变血管数量、充血性心力衰竭评分、吸烟史、射血分数、性别、左主干冠状动脉疾病的存在、糖尿病的存在、左心室壁运动评分、其他疾病的存在、心肌梗死病史以及左主干等同疾病的存在。总体而言,零支、一支、两支和三支血管病变患者的12年生存率分别为88%、74%、59%和40%。至少有一支病变血管且射血分数在50%至100%、35%至49%和0%至34%范围内的患者的12年生存率分别为73%、54%和21%。高心肌危险度、高心绞痛分级以及两支或三支近端病变血管是随访期间最有可能接受手术治疗患者的特征。
这些结果有助于理解冠状动脉疾病的自然史,也具有历史意义。三支血管病变和低射血分数患者的低生存率继续强调了对这些患者考虑血运重建的重要性。